AU2002349535A1 - Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof - Google Patents

Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof

Info

Publication number
AU2002349535A1
AU2002349535A1 AU2002349535A AU2002349535A AU2002349535A1 AU 2002349535 A1 AU2002349535 A1 AU 2002349535A1 AU 2002349535 A AU2002349535 A AU 2002349535A AU 2002349535 A AU2002349535 A AU 2002349535A AU 2002349535 A1 AU2002349535 A1 AU 2002349535A1
Authority
AU
Australia
Prior art keywords
hydrate
sodium salt
dione derivative
benzyl thiazolidine
thiazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349535A
Other languages
English (en)
Inventor
Wataru Hori
Yasumasa Iwai
Shintarou Kanazawa
Tomomi Koike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of AU2002349535A1 publication Critical patent/AU2002349535A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2002349535A 2001-12-11 2002-12-10 Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof Abandoned AU2002349535A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-377076 2001-12-11
JP2001377076 2001-12-11
PCT/JP2002/012891 WO2003050097A1 (fr) 2001-12-11 2002-12-10 Sel de sodium d'un derive benzyl thiazolidine-2,4-dione et hydrate de sel de sodium

Publications (1)

Publication Number Publication Date
AU2002349535A1 true AU2002349535A1 (en) 2003-06-23

Family

ID=19185128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349535A Abandoned AU2002349535A1 (en) 2001-12-11 2002-12-10 Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof

Country Status (3)

Country Link
JP (1) JPWO2003050097A1 (ja)
AU (1) AU2002349535A1 (ja)
WO (1) WO2003050097A1 (ja)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778723B2 (en) * 1999-08-23 2004-12-16 Kyorin Pharmaceutical Co. Ltd. Substituted benzylthiazolidine-2,4-dione derivatives

Also Published As

Publication number Publication date
WO2003050097A1 (fr) 2003-06-19
JPWO2003050097A1 (ja) 2005-04-21

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
EP1511730B8 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AU2002257497A1 (en) Derivatives of exendin
AU2003302763A1 (en) Insecticidal aminothiazole derivatives
HK1069997A1 (en) 2-amino-4,5-trisubstituted thiazolyl derivatives 2-4,5-
AU2003303240A1 (en) Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
AU4989400A (en) Stabilization of isothiazolone
AU2003252314A1 (en) 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof
AU2002349535A1 (en) Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof
HUP0300777A3 (en) Tartrate salt of thiazolidinedione derivative
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
HK1057749A1 (en) The hydrochloride salt of 5Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione
AU2003262141A1 (en) Preperation of desloratatine
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU3971700A (en) Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase
HRP20030068A2 (en) Tartrate salt of thiazolidinedione derivative
AU7961800A (en) Thiazolidinedione derivatives
HUP0300724A3 (en) Tartrate salt of thiazolidinedione derivative
AU2002366756A1 (en) Use of benzofuroxan derivatives as antiplatelet agents
AU2003260515A1 (en) Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents
AU2002253588A1 (en) Heterocyclic compound derivatives and medicines
AU2002323921A1 (en) Swing body of lure
AU2002357594A1 (en) Nitrogen-containing heterocyclic compounds and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase